Bill Text: HI HB2096 | 2010 | Regular Session | Amended

---

Bill Title: Prescription Drug Formulary

Spectrum: Partisan Bill (Democrat 3-0)

Status: (Introduced - Dead) 2010-02-24 - (H) The committee(s) recommends that the measure be deferred. [HB2096 Detail]

Download: Hawaii-2010-HB2096-Amended.html

---

 

 

STAND. COM. REP. NO.  228-10

 

Honolulu, Hawaii

                , 2010

 

RE:   H.B. No. 2096

      H.D. 1

 

 

 

 

Honorable Calvin K.Y. Say

Speaker, House of Representatives

Twenty-Fifth State Legislature

Regular Session of 2010

State of Hawaii

 

Sir:

 

     Your Committee on Health, to which was referred H.B. No. 2096 entitled:

 

"A BILL FOR AN ACT RELATING TO PRESCRIPTION DRUGS,"

 

begs leave to report as follows:

 

     The purpose of this bill is to improve the quality of care and practice of medicine in Hawaii by requiring that health plans that base coverage for prescription drugs on a drug formulary or prior authorization requirement establish a Drug Formulary Board (Board) to develop a drug formulary.

 

     The Hawaii Medical Association supported this bill.  The Hawaii Association of Health Plans opposed this measure.  The Department of Commerce and Consumer Affairs (DCCA) and ‘Ohana Health Plan submitted comments.

 

     Your Committee has amended this bill by:

 

     (1)  Requiring that the Board develop standards for review that have been approved by a majority of the Board prior to establishing a prescription drug formulary;

 

     (2)  Providing that a doctor of psychiatry may also be selected for placement on the Board;

 

     (3)  Requiring DCCA's Insurance Commissioner to provide administrative oversight to ensure compliance of the insurance plans;

 

     (4)  Changing the effective date to July 1, 2020, to encourage further discussion; and

 

     (5)  Making technical, nonsubstantive changes for clarity, consistency, and style.

 

     As affirmed by the record of votes of the members of your Committee on Health that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 2096, as amended herein, and recommends that it pass Second Reading in the form attached hereto as H.B. No. 2096, H.D. 1, and be referred to the Committee on Consumer Protection & Commerce.

 

Respectfully submitted on behalf of the members of the Committee on Health,

 

 

		____________________________ RYAN I. YAMANE, Chair